Measuring skin stiffness in breast cancer-related lymphedema
Part of Blood & lymphatic, Cancer, Skin clinical trials.
This trial tests a device called Myoton that measures skin firmness to see if it can help doctors better evaluate lymphedema (arm swelling) after breast cancer treatment. It may lead to better management of this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 80 years old
- You have swelling in only one arm after breast cancer surgery
- Your lymphedema has been diagnosed as stage 0, I, II, or III
- You are willing to take part and sign a consent form
- You do not have other conditions like serious heart problems, active infections, or skin diseases that affect skin flexibility
- You do not have a cognitive or mental condition that could affect your ability to cooperate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a noninvasive light-based treatment (photobiomodulation) can reduce breast cancer–related lymphedema, which is swelling in the arm or chest area due to lymph fluid buildup. If you qualify, you’ll be asked to follow a set treatment and follow-up schedule to see if symptoms improve safely.
This trial is testing a new wearable device and mobile app that measures arm volume changes after breast surgery. It aims to help monitor swelling (lymphedema) early, so you can get treatment sooner.
This study is looking at whether targeted therapy for breast cancer changes the risk of arm swelling (lymphedema). It is a screening trial that uses a machine to measure arm size and check for any swelling early on.
This trial looks at new tools to detect lymphedema (breast or arm swelling) after breast cancer treatment. If you had breast-conserving surgery, radiation, and have finished active therapy (except certain hormone treatments), researchers want to see if a simple device can spot fluid buildup early.
This study tests a medical device (Dayspring Technology) to reduce swelling in the arm caused by breast cancer treatment and lymph surgery. You may be eligible if you have one-sided arm swelling after lymphatic surgery and meet safety checks for the device.
This trial tests a new way to measure arm swelling (lymphedema) early in women who have had or will have breast cancer surgery. It aims to catch swelling sooner so treatment can start faster.
Hear when a new Breast Cancer Related Lymphedema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.